
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
1 Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2 Department of Medicine, Division of Gastroenterology and 3 Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina and 4 Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Requests for reprints: Deborah A. Fisher, Durham Veterans Affairs Medical Center, Duke University Medical Center, 508 Fulton Street, Building 6, Durham, NC 27705. Phone: 919-286-2287; Fax: 919-416-5839. E-mail: deborah.fisher{at}duke.edu
Background: Failure to appropriately evaluate a positive cancer screening test may negate the value of doing that test. The primary aim of this study was to explore the factors associated with undergoing a full colon evaluation for a positive fecal occult blood test (FOBT) in a single Veterans Affairs center.
Methods: Medical records of consecutive patients ages
50 years, who had a positive screening FOBT from March 2000 to February 2001, were abstracted. Patient demographics, dates of ordering and doing follow-up test(s), and adherence with scheduled procedures were collected. The primary outcome, full colon evaluation, was defined as having a colonoscopy or double-contrast barium enema plus flexible sigmoidoscopy completed within 12 months.
Results: The sample (N = 538) was 98% men (58% Caucasian, 29% African-American, and 13% unknown race). Approximately 77% of the patients were referred to gastroenterology. Ultimately, only 44% underwent full colon evaluation within 12 months. Approximately 20% of the patients failed to attend a scheduled procedure. Referral to gastroenterology and adherence to follow-up appointments were associated with full colon evaluation. There was no association between African-American versus Caucasian race and full colon evaluation.
Conclusions: Less than half of the patients with a positive FOBT had a full colon evaluation within 12 months. Multiple failures were identified, including lack of referral for further testing and patient nonadherence. Although the overall performance in evaluating a positive colorectal cancer screening test was poor, no racial disparity was observed. (Cancer Epidemiol Biomarkers Prev 2006;15(6):12325)
This article has been cited by other articles:
![]() |
L. C. Walter, K. Lindquist, S. Nugent, T. Schult, S. J. Lee, M. A. Casadei, and M. R. Partin Impact of Age and Comorbidity on Colorectal Cancer Screening Among Older Veterans Ann Intern Med, April 7, 2009; 150(7): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Sequist, A. M. Zaslavsky, R. Marshall, R. H. Fletcher, and J. Z. Ayanian Patient and Physician Reminders to Promote Colorectal Cancer Screening: A Randomized Controlled Trial Arch Intern Med, February 23, 2009; 169(4): 364 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jimbo, R. E. Myers, B. Meyer, T. Hyslop, J. Cocroft, B. J. Turner, and D. S. Weinberg Reasons Patients With a Positive Fecal Occult Blood Test Result Do Not Undergo Complete Diagnostic Evaluation Ann. Fam. Med, January 1, 2009; 7(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ladabaum When even people at high risk do not take up colorectal cancer screening Gut, December 1, 2007; 56(12): 1648 - 1650. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |